These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11675291)
1. [Clinical significance of Epstein-Barr virus load]. Dehée A Ann Biol Clin (Paris); 2001 Oct; 59 Spec No():28-33. PubMed ID: 11675291 [No Abstract] [Full Text] [Related]
2. Persistent increased Epstein-Barr virus loads after solid organ transplantation: truth and consequences? Green M; Webber SA Liver Transpl; 2007 Mar; 13(3):321-2. PubMed ID: 17318870 [No Abstract] [Full Text] [Related]
3. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS. Martin SI; Zukerberg L; Robbins GK Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622 [TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of Epstein-Barr virus. Häusler M; Scheithauer S; Ritter K; Kleines M Expert Rev Mol Diagn; 2003 Jan; 3(1):81-92. PubMed ID: 12528366 [TBL] [Abstract][Full Text] [Related]
7. Quantification of Epstein-Barr viral load and determination of a cut-off value to predict the risk of post-transplant lymphoproliferative disease in a renal transplant cohort. Baiocchi OC; Colleoni GW; Caballero OL; Vettore AL; Andrade AL; Pestana JO Haematologica; 2004 Mar; 89(3):366-8. PubMed ID: 15020282 [TBL] [Abstract][Full Text] [Related]
8. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders. Dolcetti R Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317 [TBL] [Abstract][Full Text] [Related]
9. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants]. Hidalgo M; Lumbreras C; Aguado JM Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496 [No Abstract] [Full Text] [Related]
15. First report of Epstein-Barr virus lymphoproliferative disease after cord blood transplantation. Sirvent N; Reviron D; de Lamballerie X; Michel G Bone Marrow Transplant; 2000 Jan; 25(1):120-1. PubMed ID: 10654028 [No Abstract] [Full Text] [Related]
16. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level. Orii T; Ohkohchi N; Satomi S; Hoshino Y; Kimura H Transpl Int; 2002 Nov; 15(11):529-34. PubMed ID: 12461655 [TBL] [Abstract][Full Text] [Related]
17. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol]. Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803 [TBL] [Abstract][Full Text] [Related]
18. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054 [TBL] [Abstract][Full Text] [Related]
19. Donor or recipient origin of posttransplantation lymphoproliferative disorders: the traces of the Epstein-Barr virus. Volk HD; Babel N; Reinke P Transplantation; 2001 Aug; 72(3):361-2. PubMed ID: 11502960 [No Abstract] [Full Text] [Related]
20. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]